MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

 

Report No. :

515856

Report Date :

22.06.2018

 

IDENTIFICATION DETAILS

 

Name :

HARMAN FINOCHEM LIMITED

 

 

Formerly Known As :

HARMAN FINOCHEM PRIVATE LIMITED 

 

 

Registered Office :

107-A, Vinay Bhavya Complex, 159 A, CST Road, Kalina, Santacruz (East), Mumbai – 400098, Maharashtra

Tel. No.:

91-22-26528080

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

17.03.1983

 

 

CIN No.:

[Company Identification No.]

U24110MH1983PLC029560

 

 

Capital Investment / Paid-up Capital :

INR 47.636 Million

 

 

IEC No.:

[Import-Export Code No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAB7CH3223J

 

 

GSTN :

[Goods & Service Tax Registration No.]

Not Divulged

 

 

TIN No.:

27620006688

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure sugar etc. [Registered Activity]

 

 

No. of Employees :

Information declined by the management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company incorporated in the year 1983 and it having good track records.

 

For the financial year 2017, the company has increased its revenue from operations as compared to previous year and maintained decent profit margin of 19.68%.

 

Rating takes into consideration sound financial profile of the company marked by healthy networth base and debt low balance sheet.

 

Further, rating also derives strength from established track records of business operations and improvement in the revenue profile during the year.

 

Trade relations are fair. Payment terms are seems to be regular.

 

In view of aforesaid, the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2018.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 22.06.2018.

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION DENIED 

 

Management Non-Cooperative [Tel. No.: 91-22-26528080]

 

 

LOCATIONS

 

Registered Office :

107-A, Vinay Bhavya Complex, 159 A, CST Road, Kalina, Santacruz (East), Mumbai – 400098, Maharashtra, India

Tel. No.:

91-22-26528080 / 67330100/ 67330116

Fax No.:

91-22-26528285 / 26526500

E-Mail :

harmanfinochem@vsnl.com

Info@harmanfinochem.com

sukhvinder@harmanfinochem.com

sales@harmanfinochem.com

Website :

http://www.harmanfinochem.com

 

 

Factory 1 :

A/100, 5 Star Industrial Area, Shendra, Aurangabad - 431210, Maharashtra –India

 

 

Factory 2 :

Chikalthana, Aurangabad, Maharashtra, India

 

 

DIRECTORS

 

As on 31.03.2018

 

Name :

Mr. Bhupinder Singh Jagdev Singh Manhas

Designation :

Managing Director

Address :

Manhas Mansion, 13/292, CST Road, Kalina, Santacruz (East), Mumbai – 400098, Maharashtra, India

Date of Birth/Age :

01.04.1950

Qualification :

M.Sc.

Date of Appointment :

17.03.1983

PAN No.:

AAEPM3341C

DIN No.:

00121253

 

 

Name :

Mrs. Inderjit Kaur Bhupinder Singh Manhas

Designation :

Whole time Director

Address :

B/14, Manhas Mansion, Vidya Nagari Marg, Kalina, Mumbai – 400098, Maharashtra, India

Date of Birth/Age :

23.10.1951

Date of Appointment :

01.04.2013

PAN No.:

ADNPM5093K

DIN No.:

00121284

 

 

Name :

Mr. Harpreet Singh Bhupinder Singh Minhas

Designation :

Whole time Director

Address :

Manhas Mansion, 13/292, CST Road, Kalina, Santacruz (East), Mumbai – 400098, Maharashtra, India

Date of Birth/Age :

02.09.1976

Qualification :

MBA

Date of Appointment :

01.04.2013

PAN No.:

AAEPM3340D

DIN No.:

00121336

 

 

Name :

Mr. Gurpreet Singh Bhupinder Singh Manhas

Designation :

Director

Address :

Manhas Mansion, 13/292, CST Road, Kalina, Santacruz (East), Mumbai – 400098, Maharashtra, India

Date of Birth/Age :

03.12.1979

Date of Appointment :

30.09.2014

DIN No.:

01885368

 

 

Name :

Mr. Savreen Minhas

Designation :

Director

Address :

Manhas Mansion, 13/292, CST Road, Kalina, Santacruz (East), Mumbai – 400098, Maharashtra, India

Date of Birth/Age :

05.01.1980

Date of Appointment :

30.09.2014

DIN No.:

06838530

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 31.03.2017

 

Names of Shareholders

 

No. of Shares

Bhupinder Singh Manhas jointly with Inderjeet Kaur B Manhas

 

1618100

Bhupinder Singh Manhas (HUF)

 

118800

Harpreet Singh Manhas jointly with Savreen Minhas

 

707785

Inderjeet Kaur Manhas

 

900000

Gurpreet Singh Minhas

 

707785

Shyamsunder Shenoy

 

30

Unnikrishnan Parakkat

 

30

Wellworth Medicines Private Limited, India

 

682070

Kirti Mercantile Private Limited, India

 

29000

 

 

 

Total

 

4763600

 

Equity Share Break up (Percentage of Total Equity)

 

As on 29.09.2017

 

Category

Percentage

Promoter – (Individual/ Hindu Undivided Family – Indian)

85.07

Promoter - Bodies corporate

14.93

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure sugar etc. [Registered Activity]

 

 

Products :

Item Code No.

Product Description

98020000

Manufacture of medicinal substances

used in the manufacture of pharmaceuticals

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

PRODUCTION STATUS NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Information declined by the management

 

 

Bankers :

Bank Name

Allahabad Bank

Branch

Industrial Finance Branch, Mumbai Samachar Marg, Fort, Mumbai - 400023, Maharashtra, India

Person Name (With Designation)

--

Contact Number

--

Name of Account Holder

--

Account Number

--

Account Since (Date/Year of Account Opening)

--

Average Balance Maintained (If Possible)

--

Credit Facilities Enjoyed (If any)

--

Account Operation

--

Remarks (If any)

--

 

 

Facilities :

Secured Loan

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Working capital loans from banks

246.199

9.516

Rupee term loans from banks

9.054

6.327

 

 

 

Total

255.253

15.843

 

Auditors :

 

Name :

K.U. Kothari and Company

Chartered Accountants

Address :

A/1-205, Laram Centre, S.V. Road, Andheri (West), Mumbai – 400058, Maharashtra, India

E-Mail :

kukothari@rediffmail.com

Income-tax PAN of auditor or auditor's firm :

AADFK0855C

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Associates :

Wellworth Medicines Private Limited

U24230MH1989PTC132889

 

 

Subsidiaries :

Shreefal Engineering Private Limited

U29252MH2010PTC204950

 

 

CAPITAL STRUCTURE

 

As on 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5000000

Equity Shares

INR 10/- each

INR 50.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4763600

Equity Shares

INR 10/- each

INR 47.636 Million

 

 

 

 

 

 

 

 

 

 

 

                                                                   


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

47.636

47.636

47.636

(b) Reserves and Surplus

4469.211

3783.319

3052.427

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

4516.847

3830.955

3100.063

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

332.053

15.843

4.779

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long-term liabilities

0.015

13.695

13.695

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

332.068

29.538

18.474

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

0.000

0.000

0.000

(b) Trade payables

372.791

351.439

248.297

(c) Other current liabilities

16.179

15.650

31.351

(d) Short-term provisions

61.937

31.848

35.783

Total Current Liabilities (4)

450.907

398.937

315.431

 

 

 

 

TOTAL

5299.822

4259.430

3433.968

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1791.007

1619.473

1417.051

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Tangible assets capital work-in-progress

1338.340

476.493

200.216

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

52.196

438.536

535.404

(c) Deferred tax assets (net)

20.107

12.761

12.761

(d) Long-term loans and advances

184.089

134.557

114.509

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

3385.739

2681.820

2279.941

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

356.854

219.082

199.578

(c) Trade receivables

862.451

736.019

538.651

(d) Cash and bank balances

276.778

235.941

184.933

(e) Short-term loans and advances

418.000

386.568

230.865

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

1914.083

1577.610

1154.027

 

 

 

 

TOTAL

5299.822

4259.430

3433.968

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Total Revenue from operations

3499.117

3358.397

3119.536

 

Other Income

113.130

170.339

111.635

 

TOTAL

3612.247

3528.736

3231.171

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

1458.930

1430.341

1429.430

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

1.749

4.609

11.157

 

Employee benefit expense

433.660

368.186

293.508

 

CSR expenditure

9.062

10.815

9.983

 

Other expenses

435.683

413.144

345.855

 

TOTAL

2339.084

2227.095

2089.933

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

1273.163

1301.641

1141.238

 

 

 

 

 

Less

FINANCIAL EXPENSES

18.239

10.041

6.581

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

1254.924

1291.600

1134.657

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

240.945

214.820

157.870

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

1013.979

1076.780

976.787

 

 

 

 

 

Less

TAX

325.229

343.030

317.370

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

688.750

733.750

659.417

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

144.00

154.00

138.00

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

0.000

0.000

0.000

Net cash flows from (used in) operations

852.842

833.057

783.277

Net cash flows from (used in) operating activities

520.268

490.027

468.025

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

[Sundry Debtors / Income * 365]

 

89.96

79.99

63.02

 

 

 

 

 

Account Receivables Turnover

[Income / Sunday Debtors]

 

4.06

4.56

5.79

 

 

 

 

 

Average Payment Days [Sundry Creditors / Purchases * 365]

 

93.27

89.68

63.40

 

 

 

 

 

Inventory Turnover [Operating Income / Inventories]

 

3.57

5.94

5.72

 

 

 

 

 

Asset Turnover [Operating Income / Net Fixed Assets]

 

0.41

0.62

0.71

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio [(Borrowing + Current Liabilities) / Total Assets]

 

0.15

0.10

0.09

 

 

 

 

 

Debt Equity Ratio (Borrowings / NetWorth)

 

0.07

0.00

0.00

 

 

 

 

 

Current Liabilities to Networth (Current Liabilities / NetWorth)

 

0.10

0.10

0.10

 

 

 

 

 

Fixed Assets to NetWorth (Net Fixed Assets / NetWorth)

 

0.69

0.55

0.52

 

 

 

 

 

Interest Coverage Ratio [PBIT / Financial Charges]

 

69.80

129.63

173.41

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin [(PAT / Sales) * 100]

(%)

19.68

21.85

21.14

 

 

 

 

 

Return on Total Assets [(PAT / Total Assets) * 100]

(%)

13.00

17.23

19.20

 

 

 

 

 

Return on Investment (ROI) [(PAT / NetWorth) * 100]

(%)

15.25

19.15

21.27

 

 

SOLVENCY RATIO

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio [Current Assets / Current Liabilities]

 

4.24

3.95

3.66

 

 

 

 

 

Quick Ratio [(Current Assets - Inventories) / Current Liabilities]

 

3.45

3.41

3.03

 

 

 

 

 

G-Score Ratio Financial [NetWorth / Total Assets]

 

0.85

0.90

0.90

 

 

 

 

 

G-Score Ratio Debt [Debts / Equity Capital]

 

6.97

0.33

0.10

 

 

 

 

 

G-Score Ratio Liquidity [Total Current Assets / Total Current Liabilities]

 

4.24

3.95

3.66

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

47.636

47.636

47.636

Reserves & Surplus

3052.427

3783.319

4469.211

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

3100.063

3830.955

4516.847

 

 

 

 

Long-term borrowings

4.779

15.843

332.053

Short term borrowings

0.000

0.000

0.000

Total borrowings

4.779

15.843

332.053

Debt/Equity ratio

0.002

0.004

0.074

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

3119.536

3358.397

3499.117

 

 

7.657

4.190

 

 


 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

3119.536

3358.397

3499.117

Profit/ (Loss)

659.417

733.750

688.750

 

21.14 %

21.85 %

19.68 %

 

 

 

ABRIDGED BALANCE SHEET – (CONSOLIDATED)

 

SOURCES OF FUNDS

 

 

31.03.2017

31.03.2016

III.           EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

47.636

47.636

(b) Reserves and Surplus

 

4492.434

3806.802

(c) Money received against share warrants

 

0.000

0.000

(d) Minority interest

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

4540.070

3854.438

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

332.053

15.843

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long-term liabilities

 

0.015

13.695

(d) long-term provisions

 

0.000

0.000

Total Non-current Liabilities (3)

 

332.068

29.538

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

 

0.000

0.000

(b) Trade payables

 

372.791

351.439

(c) Other current liabilities

 

16.178

15.650

(d) Short-term provisions

 

61.975

31.874

Total Current Liabilities (4)

 

450.944

398.963

 

 

 

 

TOTAL

 

5323.082

4282.939

 

 

 

 

IV.           ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

1801.307

1629.773

(ii) Intangible Assets

 

12.510

12.510

(iii) Tangible assets capital work-in-progress

 

1356.361

492.582

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

52.455

439.056

(c) Deferred tax assets (net)

 

20.107

12.761

(d) Long-term loans and advances

 

184.598

135.066

(e) Other Non-current assets

 

0.517

0.486

Total Non-Current Assets

 

3427.855

2722.234

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

356.854

219.082

(c) Trade receivables

 

862.451

736.019

(d) Cash and bank balances

 

276.793

235.956

(e) Short-term loans and advances

 

399.129

369.648

(f) Other current assets

 

0.000

0.000

Total Current Assets

 

1895.227

1560.705

 

 

 

 

TOTAL

 

5323.082

4282.939

 

 

PROFIT & LOSS ACCOUNT– (CONSOLIDATED)

 

 

PARTICULARS

 

 

31.03.2017

31.03.2016

 

SALES

 

 

 

 

Total Revenue from operations

 

3499.117

3358.397

 

Other Income

 

113.130

170.339

 

TOTAL

 

3612.247

3528.736

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

 

1458.930

1430.341

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

1.749

4.609

 

Employee benefit expense

 

433.660

368.186

 

CSR expenditure

 

9.062

10.815

 

Other expenses

 

435.683

413.143

 

TOTAL

 

2339.084

2227.094

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

1273.163

1301.642

 

 

 

 

 

Less

FINANCIAL EXPENSES

 

18.239

10.041

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

1254.924

1291.601

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION

 

240.945

214.821

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

 

1013.979

1076.780

 

 

 

 

 

Less

TAX

 

325.229

343.030

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

 

688.750

733.750

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

 

145.00

154.00

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

UNSECURED LOAN

 

Unsecured Loan

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Loans and advances from related parties

76.800

0.000

 

 

 

Total

76.800

0.000

 

 

INDEX OF CHARGES:

 

Charges Registered

SNo

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

G22248678

100060185

KOTAK MAHINDRA BANK LIMITED

26/03/2016

-

-

250000000.0

27BKC, C 27, G Block, Bandra Kurla Complex, Bandra (East), Mumbai MH 400051 IN

2

G32897985

90239691

Allahabad Bank

21/01/1992

26/09/2016

-

350000000.0

Industrial Finance Branch,2nd Floor, 37 Allahabad Bank Building, Mumbai Samachar Marg, Fort Mumbai 400023 IN

 

 

FIXED ASSETS

 

  • Land
  • Buildings
  • Office building
  • Plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Aircrafts helicopters
  • Motor vehicles
  • Office equipment
  • Computer equipment

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 68.15

UK Pound

1

INR 90.31

Euro

1

INR 79.16

 

 

INFORMATION DETAILS

 

Information Gathered by :

KMN

 

 

Analysis Done by :

PRA

 

 

Report Prepared by :

JYO


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.